91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

TTT-3002

有货

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
T614576-5mg
5mg 期货 Stock Image
T614576-25mg
25mg 期货 Stock Image

基本描述

英文名称 TTT-3002
别名 TTT3002
英文别名 TTT3002

名称和标识符

INCHI InChI=1S/C27H23N5O3/c1-26-27(28,25(34)29-2)11-18(35-26)31-16-9-5-3-7-13(16)20-21-15(12-30-24(21)33)19-14-8-4-6-10-17(14)32(26)23(19)22(20)31/h3-10,18H,11-12,28H2,1-2H3,(H,29,34)(H,30,33)/t18-,26+,27-/m0/s1
InChi Key DCAYZGCTSXLIHO-FYCNXDEQSA-N
Canonical SMILES CNC(=O)[C@@]1(N)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c1c1n2c2ccccc2c1c1c3CNC1=O
PubChem CID 92136143

关联配体

Ligand ID 11134
名称 TTT-3002
别名 TTT3002
类别 Synthetic organic
学名 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide
生物活性评价 The antiproliferative activity of TTT-3002 in cancer cell lines is more potent in FLT3-dependent cells (those with activating mutations or high levels of WT expression and autocrine activation) compared to FLT3-independent cell lines .
评价 TTT-3002 is an experimental indolocarbazole kinase inhibitor. It was originally reported as a LRRK2 inhibitor (including activity against the G2019S and R1441C mutations) . Subsequent analysis revealed that TTT-3002 overcomes activating and drug resistance mutations in FLT3 in acute myeloid leukemia cells and is active against FLT3-associated leukemias in vitro and in vivo .

相关文档

质检报告COA

请输入批号:


产品问答

产品问答

登录提交问题 Hover me 请先登录再提交问题
您提交该产品问题后,我们会在1-2个工作日内给您答复,您可以登录"我的账号",然后点击"我的产品问答"查看答案

参考文献

1. Yao C, Johnson WM, Gao Y, Wang W, Zhang J, Deak M, Alessi DR, Zhu X, Mieyal JJ, Roder H et al..  (2013)  Kinase inhibitors arrest neurodegeneration in cell and C. elegans models of LRRK2 toxicity..  Hum Mol Genet,  22  (2):  (328-44).  [PMID:23065705]
2. Ma H, Nguyen B, Li L, Greenblatt S, Williams A, Zhao M, Levis M, Rudek M, Duffield A, Small D.  (2014)  TTT-3002 is a novel FLT3 tyrosine kinase inhibitor with activity against FLT3-associated leukemias in vitro and in vivo..  Blood,  123  (10):  (1525-34).  [PMID:24408321]
3. Ma HS, Nguyen B, Duffield AS, Li L, Galanis A, Williams AB, Brown PA, Levis MJ, Leahy DJ, Small D.  (2014)  FLT3 kinase inhibitor TTT-3002 overcomes both activating and drug resistance mutations in FLT3 in acute myeloid leukemia..  Cancer Res,  74  (18):  (5206-17).  [PMID:25060518]

91高清自产国产拍,无码免费A级毛片大全,日本 欧美 国产中文字幕,99re热视频这里只有精品视频首页

品牌简介

{转码主词}